We're tracking Redmile Ltd's market expansion
How Redmile Ltd's international expansion compares to its competitors
Redmile LtdYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Redmile LtdYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Boulder-based Ambrosia Biosciences secured $100 million in oversubscribed Series B funding to advance its oral small molecule GLP-1 through clinical trials, led by Blue Owl, Redmile, and Deep Track Capital.
Be the first to find verified contacts at Redmile Ltd
Quick answers about Redmile Ltd's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
